Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.

Saved in:
Bibliographic Details
Title: Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.
Authors: Dagenais GR; Department of Cardiology, Laval University Heart and Lung Institute, Quebec, Québec, Canada gilles.dagenais@criucpq.ulaval.ca., Dyal L; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Bosch JJ; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Leong DP; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Aboyans V; Department of Cardiology, Dupuytren University Hospital, Limoges, France.; Department of Cardiology, INSERM, U1094, Tropical Neuroepidemiology, Limoges, France., Berkowitz SD; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA., Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts, USA., Connolly SJ; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Fox KAA; Department of Medicine, University of Edinburgh, Edinburgh, UK., Muehlhofer E; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA., Probstfield JL; Department of Medicine (Cardiology), University of Washington Medical Centre, Seattle, Washington, USA., Widimsky P; Cardiocenter, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University Prague, Prague, Czech Republic., Winkelmann BR; Kardiologische Studienpraxis und ClinPhenomics GmbH&Co, Studienzentrum Schaumainkai Frankfurt, Frankfurt, Germany., Yusuf S; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Eikelboom JW; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada.
Source: Heart (British Cardiac Society) [Heart] 2021 Jul; Vol. 107 (14), pp. 1130-1137. Date of Electronic Publication: 2021 May 21.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9602087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-201X (Electronic) Linking ISSN: 13556037 NLM ISO Abbreviation: Heart Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-201X
DOI:10.1136/heartjnl-2020-318758